BRPI0512963A - produto compreendendo um antibiótico de (beta)-lactama - Google Patents
produto compreendendo um antibiótico de (beta)-lactamaInfo
- Publication number
- BRPI0512963A BRPI0512963A BRPI0512963-0A BRPI0512963A BRPI0512963A BR PI0512963 A BRPI0512963 A BR PI0512963A BR PI0512963 A BRPI0512963 A BR PI0512963A BR PI0512963 A BRPI0512963 A BR PI0512963A
- Authority
- BR
- Brazil
- Prior art keywords
- lactam antibiotic
- product
- beta
- cephalosporin
- drying
- Prior art date
Links
- 230000003115 biocidal effect Effects 0.000 title 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 abstract 4
- 239000002132 β-lactam antibiotic Substances 0.000 abstract 4
- 229940124586 β-lactam antibiotics Drugs 0.000 abstract 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract 2
- 229930186147 Cephalosporin Natural products 0.000 abstract 2
- 229940124587 cephalosporin Drugs 0.000 abstract 2
- 150000001780 cephalosporins Chemical class 0.000 abstract 2
- 238000001035 drying Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
- B01J2/12—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic in rotating drums
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
PRODUTO COMPREENDENDO UM AXTIBIóTICO DE ß-LACTAMA A presente invenção refere-se a um produto que compreende um antibiótico de ß-lactama, por exemplo, uma cefalosporina, o referido produto contendo menos que 200 mg de acetona por kg de antibiótico de ß-lactama. A invenção também se refere a um processo para secagem de um antibiótico de ß-lactama, por exemplo, uma cefalosporina, o referido processo compreendendo a secagem do referido antibiótico de ß-lactama sob pressão diminuída.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04077518 | 2004-06-30 | ||
| PCT/EP2005/053035 WO2006003151A1 (en) | 2004-06-30 | 2005-06-28 | Product comprising a beta-lactam antibiotic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0512963A true BRPI0512963A (pt) | 2008-04-22 |
Family
ID=34928503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0512963-0A BRPI0512963A (pt) | 2004-06-30 | 2005-06-28 | produto compreendendo um antibiótico de (beta)-lactama |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20080031955A1 (pt) |
| EP (1) | EP1761328A1 (pt) |
| KR (1) | KR20070036088A (pt) |
| CN (1) | CN1976747A (pt) |
| BR (1) | BRPI0512963A (pt) |
| WO (1) | WO2006003151A1 (pt) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3655656A (en) * | 1970-06-04 | 1972-04-11 | Lilly Co Eli | Crystalline cephalexin monohydrate |
| GB1489235A (en) * | 1974-03-28 | 1977-10-19 | Beecham Group Ltd | Antibiotics |
| JPS525787A (en) * | 1975-06-27 | 1977-01-17 | Bristol Myers Co | Antiibacterial agent |
| JPS5329936A (en) * | 1976-08-31 | 1978-03-20 | Takeda Chem Ind Ltd | Antibiotic composition |
| US4293539A (en) * | 1979-09-12 | 1981-10-06 | Eli Lilly And Company | Controlled release formulations and method of treatment |
| AU4846196A (en) * | 1995-02-02 | 1996-08-21 | Chemferm V.O.F. | Process for the recovery of cephalexin |
-
2005
- 2005-06-28 BR BRPI0512963-0A patent/BRPI0512963A/pt not_active IP Right Cessation
- 2005-06-28 WO PCT/EP2005/053035 patent/WO2006003151A1/en not_active Ceased
- 2005-06-28 KR KR1020067027822A patent/KR20070036088A/ko not_active Withdrawn
- 2005-06-28 CN CNA2005800221573A patent/CN1976747A/zh active Pending
- 2005-06-28 EP EP05764061A patent/EP1761328A1/en not_active Withdrawn
- 2005-06-28 US US11/630,269 patent/US20080031955A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006003151A1 (en) | 2006-01-12 |
| EP1761328A1 (en) | 2007-03-14 |
| KR20070036088A (ko) | 2007-04-02 |
| CN1976747A (zh) | 2007-06-06 |
| US20080031955A1 (en) | 2008-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4167994A4 (en) | 2-OXO-OXAZOLIDINE-5-CARBOXAMIDE AS NAV1.8 INHIBITORS | |
| WO2007061923A3 (en) | Glucokinase activators | |
| BR0010555A (pt) | Inibidores de neuraminidases | |
| WO2008012542A8 (en) | Polysaccharide derivatives of erythropoietin | |
| WO2007075847A3 (en) | Glucokinase activators | |
| WO2007104034A3 (en) | Glucokinase activators | |
| WO2008116107A3 (en) | Piperazine derivatives as glucokinase activators | |
| SI1888604T1 (sl) | Postopek priprave (alfa s, beta r)-6-bromo-alfa-(2-(dimetilamino) etil)2-metoksi-alfa-1-naftalenil-beta-fenil-3-kinolinetanola | |
| UA102817C2 (ru) | Способ синтеза агомелатина | |
| BRPI0712889A8 (pt) | composto, processo para a preparação de um composto, composto intermediário, e, composição farmacêutica. | |
| EP4046999A4 (en) | AMINOPYRIMIDINE COMPOUND USED AS TRIPLE INHIBITOR OF CDK2/4/6 | |
| WO2004050663A3 (en) | An improved process for the preparation of cefuroxime sodium | |
| AU2003272933A1 (en) | Process for the production of resin compositions | |
| PL1904482T3 (pl) | Pochodne indolilomaleimidowe | |
| DE60231728D1 (de) | Koaxialkabel, welches ein dielektrisches Material enthält | |
| AU2003258667A1 (en) | Method for the production by fermentation of sulphur-containing fine chemicals (metf) | |
| BRPI0512963A (pt) | produto compreendendo um antibiótico de (beta)-lactama | |
| BR0008510A (pt) | Sistemas policìclicos de 2-amino-tiazol, processo para a sua preparação e medicamento contendo estes compostos | |
| BRPI0607701A2 (pt) | composto ou um sal, éster, solvato, estereoisÈmero, tautÈmero ou pró-droga farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de uma quantidade antibacterialmente eficaz de um composto junto com um veìculo farmaceuticamente aceitável, e, método de preparação de um composto | |
| AU2003276330A1 (en) | Novel compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of alpha-perfluoroalkylamines | |
| CA3288775A1 (en) | Novel compounds as .alpha.4.beta.7 inhibitors | |
| MXPA04003085A (es) | Proceso estereoespecifico para sintesis de derivados de 2-il cromano. | |
| CA3297623A1 (en) | Pharmaceutical composition comprising 1,3-benzodioxole derivative compound | |
| HK40107227A (en) | Pharmaceutical composition comprising the compound smtp-7 | |
| HK40110664B (en) | Synthesis method for 7,8-dihydro-2h-cyclopentapyrrolopyrazinone compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |